Supriya Lifescience Limited (SUPRIYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs555.65 Million ≈ $6.01 Million USD) by net assets (Rs10.82 Billion ≈ $116.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Supriya Lifescience Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Supriya Lifescience Limited (SUPRIYA) total liabilities for a breakdown of total debt and financial obligations.

Supriya Lifescience Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Supriya Lifescience Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PWR Holdings Ltd AU:PWH	0.159x
Jiangxi Huawu Brake Co Ltd SHE:300095	0.034x
Tipco Asphalt Public Company Limited F:NVP5	0.092x
Poly Union Chemical Holding Group Co Ltd SHE:002037	0.014x
Biglari Holdings Inc NYSE:BH	0.034x
Northpointe Bancshares, Inc. NYSE:NPB	0.159x
Hamaton Automotive Technology Co Ltd SHE:300643	0.037x
Sun International Ltd JSE:SUI	0.548x

Annual Cash Flow Conversion Efficiency for Supriya Lifescience Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see SUPRIYA stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs9.97 Billion ≈ $107.80 Million	Rs1.73 Billion ≈ $18.66 Million	0.173x	+24.58%
2024-03-31	Rs8.15 Billion ≈ $88.18 Million	Rs1.13 Billion ≈ $12.25 Million	0.139x	+46.86%
2023-03-31	Rs6.99 Billion ≈ $75.64 Million	Rs661.87 Million ≈ $7.16 Million	0.095x	+19.38%
2022-03-31	Rs6.16 Billion ≈ $66.58 Million	Rs488.01 Million ≈ $5.28 Million	0.079x	-73.33%
2021-03-31	Rs2.69 Billion ≈ $29.08 Million	Rs799.30 Million ≈ $8.64 Million	0.297x	-61.80%
2020-03-31	Rs1.49 Billion ≈ $16.13 Million	Rs1.16 Billion ≈ $12.55 Million	0.778x	+49.91%
2019-03-31	Rs937.91 Million ≈ $10.14 Million	Rs486.72 Million ≈ $5.26 Million	0.519x	+62.52%
2018-03-31	Rs546.57 Million ≈ $5.91 Million	Rs174.52 Million ≈ $1.89 Million	0.319x	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$604.83 Million

Rs55.93 Billion INR

Market Cap Rank

#11566 Global

#547 in India

Share Price

Rs694.90

Change (1 day)

-0.48%

52-Week Range

Rs553.35 - Rs802.65

All Time High

Rs806.85